OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy
Metabolites (2020) Vol. 10, Iss. 7, pp. 283-283
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis
Marc Schoeler, Sandrine Ellero‐Simatos, Till Birkner, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40

PARPs in lipid metabolism and related diseases
Magdolna Szántó, Rebecca Gupte, W. Lee Kraus, et al.
Progress in Lipid Research (2021) Vol. 84, pp. 101117-101117
Open Access | Times Cited: 97

The Role of the NLRP3 Inflammasome and Programmed Cell Death in Acute Liver Injury
Chaoqun Yu, Peng Chen, Longyu Miao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3067-3067
Open Access | Times Cited: 37

Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis
Arnab Banerjee, Debasmita Das, Sandip Mukherjee, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112091-112091
Closed Access | Times Cited: 7

Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
Marina Serrano‐Maciá, Jorge Simón, Maria J. González-Rellan, et al.
Molecular Metabolism (2021) Vol. 53, pp. 101275-101275
Open Access | Times Cited: 34

Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation
Navya Malladi, Devidas Lahamge, Balaji Sanjay Somwanshi, et al.
Cellular Signalling (2024) Vol. 121, pp. 111299-111299
Closed Access | Times Cited: 4

Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression
Anindita Banerjee, Patrizia Farci
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8641-8641
Open Access | Times Cited: 4

Alternative RNA Splicing in Fatty Liver Disease
Panyisha Wu, Moya Zhang, Nicholas J. G. Webster
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 30

Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy
Jonathan Mertens, Christophe De Block, Maarten Spinhoven, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27

Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology
Veera Ganesh Yerra, Konstantinos Drosatos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4682-4682
Open Access | Times Cited: 12

Hepatocyte FBXW7-dependent activity of nutrient-sensing nuclear receptors controls systemic energy homeostasis and NASH progression in male mice
Hui Xia, Catherine R. Dufour, Younes Medkour, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12

Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD
Charles Drummer, Fatma Saaoud, Yu Sun, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-35
Open Access | Times Cited: 24

Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways
Usman Sabir, Hafiz Muhammad Irfan, Alamgeer Umme Habiba Hasan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 7, pp. 741-755
Closed Access | Times Cited: 17

Dramatic Suppression of Lipogenesis and No Increase in Beta-Oxidation Gene Expression Are among the Key Effects of Bergamot Flavonoids in Fatty Liver Disease
Maddalena Parafati, Daniele La Russa, Antonella Lascala, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 766-766
Open Access | Times Cited: 2

LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease
Jibeom Lee, Hyeonhui Kim, Yun-Won Kang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1479-1491
Open Access | Times Cited: 5

Genistein and Sex Hormone Supplementation Modulated Hepatic PPARα, δ, and γ Subtypes and STAT1 Expressions in a NASH Rat Model with Bilateral Orchidectomy
Fatist Okrit, Maneerat Chayanupatkul, Prasong Siriviriyakul, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 483-483
Open Access | Times Cited: 1

Changes in Macronutrients during Dieting Lead to Weight Cycling and Metabolic Complications in Mouse Model
Anouk Charlot, Anthony Bringolf, L. Debrut, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 646-646
Open Access | Times Cited: 1

E4bp4-Cyp3a11 axis in high-fat diet-induced obese mice with weight fluctuation
Shuoshuo Sun, Ruixiang Zhang, Yu Chen, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1

Chronic Disruption of the Late Cholesterol Synthesis Leads to Female-Prevalent Liver Cancer
Kaja Blagotinšek Cokan, Žiga Urlep, Gregor Lorbek, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3302-3302
Open Access | Times Cited: 9

Circadian rhythms and inflammatory diseases of the liver and gut
Jessica M. Ferrell
Liver Research (2023)
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top